Convergent Therapeutics
Biotechnology Research • 
Cambridge, Massachusetts, United States • 21-50 Employees
Company overview
| Headquarters | Cambridge, Massachusetts, United States |
| Phone number | +16177104289 |
| Website | |
| NAICS | 541714 |
| Founded | 2021 |
| Employees | 21-50 |
| Socials |
Key Contacts at Convergent Therapeutics
Anusha Ramachandran
Director, Cmc Operations
Shrinav Shah
Associate Director, Patient Supply Chain
Kyu Jun Son
Senior Director Corporate Development
Holly Anderson
Associate Director Of Cmc
Paige Loelkes
Senior Director Of Operations
Andrea Banks Mcfadden
Director, Quality Operations
Jillian Curiale
Senior Director, Finance
Ndidi Onwudiwe
Director Of Clinical Operations
Brett Vaughn
Associate Director, Radiopharmaceuticals
Convergent Therapeutics Email Formats
Convergent Therapeutics uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@convergentrx.com), used 73.3% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@convergentrx.com | 73.3% |
{first name}.{last name} | john.doe@convergentrx.com | 26.7% |
About Convergent Therapeutics
Convergent Therapeutics is a clinical-stage biotechnology company exploring the full potential of dual-targeted combination strategies to treat cancer. Convergent has developed a therapeutic platform that is capable of targeting validated and novel cancer antigens. Building on breakthrough research developed by Dr. Neil Bander at Weill Cornell Medicine, Convergent has demonstrated that dual targeting of surface cancer molecules like Prostate-Specific Membrane Antigen (PSMA) improves antitumor efficacy. By leveraging targeting agents with different bio-distributions, such as monoclonal antibodies and ligands, supra-additive therapeutic doses are delivered to tumor cells without additive toxicity to the patient.
Convergent Therapeutics revenue & valuation
| Annual revenue | $92,000,000 |
| Revenue per employee | $3,539,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $294,400,000 |
| Total funding | $174,400,000 |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Convergent Therapeutics has 6 employees across 4 departments.
Departments
Number of employees
Funding Data
Explore Convergent Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
Convergent Therapeutics Tech Stack
Discover the technologies and tools that power Convergent Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Security
JavaScript libraries
Analytics
JavaScript libraries
WordPress themes
Miscellaneous
Page builders
JavaScript libraries
CDN
Font scripts
JavaScript libraries
Miscellaneous
France
Spain
United Kingdom
Frequently asked questions
4.8
40,000 users
